Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E10A with Cisplatin and Paclitaxel in Head and Neck Cancer
NCT00634595Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Mar 2008
- Primary completion
- Dec 2010
- Modality
- Gene Editing, Gene Silencing, Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of Recombinant human endostatin adenovirus in head and neck squamous cell carcinoma (HNSCC), nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
Recombinant human endostatin adenovirus
03
Conditions
head and neck squamous cell carcinoma (HNSCC)nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00634595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00634595.